Concordia Puts Up $1.2B For PE-Backed Drugmaker
Rare disease specialist Concordia Healthcare Corp. said Monday it would shell out $1.2 billion in cash for piece of Covis Pharma Holdings SARL, the private equity-backed maker of more than a...To view the full article, register now.
Already a subscriber? Click here to view full article